Shagisultanova EI - Search Results

1

EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer.

Beck TN, Georgopoulos R, Shagisultanova EI, Sarcu D, Handorf EA, Dubyk C, Lango MN, Ridge JA, Astsaturov I, Serebriiskii IG, Burtness BA, Mehra R, Golemis EA. Beck TN, et al. Among authors: shagisultanova ei. Mol Cancer Ther. 2016 Oct;15(10):2486-2497. doi: 10.1158/1535-7163.MCT-16-0243. Epub 2016 Aug 9. Mol Cancer Ther. 2016. PMID: 27507850 Free PMC article.

2

Issues in interpreting the in vivo activity of Aurora-A.

Shagisultanova E, Dunbrack RL Jr, Golemis EA. Shagisultanova E, et al. Expert Opin Ther Targets. 2015 Feb;19(2):187-200. doi: 10.1517/14728222.2014.981154. Epub 2014 Nov 11. Expert Opin Ther Targets. 2015. PMID: 25384454 Free PMC article. Review.

3

Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.

Shagisultanova E, Gaponova AV, Gabbasov R, Nicolas E, Golemis EA. Shagisultanova E, et al. Gene. 2015 Aug 1;567(1):1-11. doi: 10.1016/j.gene.2015.04.086. Epub 2015 May 9. Gene. 2015. PMID: 25967390 Free PMC article. Review.

4

Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.

Korobeynikov V, Borakove M, Feng Y, Wuest WM, Koval AB, Nikonova AS, Serebriiskii I, Chernoff J, Borges VF, Golemis EA, Shagisultanova E. Korobeynikov V, et al. Breast Cancer Res Treat. 2019 Sep;177(2):369-382. doi: 10.1007/s10549-019-05329-2. Epub 2019 Jun 28. Breast Cancer Res Treat. 2019. PMID: 31254157 Free PMC article.

5

Triple Targeting of Breast Tumors Driven by Hormonal Receptors and HER2.

Shagisultanova E, Crump LS, Borakove M, Hall JK, Rasti AR, Harrison BA, Kabos P, Lyons TR, Borges VF. Shagisultanova E, et al. Mol Cancer Ther. 2022 Jan;21(1):48-57. doi: 10.1158/1535-7163.MCT-21-0098. Epub 2021 Nov 2. Mol Cancer Ther. 2022. PMID: 34728571 Free PMC article.

6

The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?

Jasem J, Fisher CM, Amini A, Shagisultanova E, Rabinovitch R, Borges VF, Elias A, Kabos P. Jasem J, et al. J Natl Compr Canc Netw. 2017 Apr;15(4):494-503. doi: 10.6004/jnccn.2017.0049. J Natl Compr Canc Netw. 2017. PMID: 28404760

7

Preclinical rationale for combination of crizotinib with mitomycin C for the treatment of advanced colorectal cancer.

Lev A, Deihimi S, Shagisultanova E, Xiu J, Lulla AR, Dicker DT, El-Deiry WS. Lev A, et al. Cancer Biol Ther. 2017 Sep 2;18(9):694-704. doi: 10.1080/15384047.2017.1364323. Epub 2017 Sep 8. Cancer Biol Ther. 2017. PMID: 28886275 Free PMC article.

8

Triple-negative breast cancer in the elderly.

Shagisultanova E, Mayordomo J, Elias AD. Shagisultanova E, et al. Breast J. 2017 Nov;23(6):627-629. doi: 10.1111/tbj.12814. Breast J. 2017. PMID: 29112794 No abstract available.

9

Overcoming Therapeutic Resistance of Triple Positive Breast Cancer with CDK4/6 Inhibition.

Schedin TB, Borges VF, Shagisultanova E. Schedin TB, et al. Int J Breast Cancer. 2018 Jun 19;2018:7835095. doi: 10.1155/2018/7835095. eCollection 2018. Int J Breast Cancer. 2018. PMID: 30018827 Free PMC article. Review.

10

Moving Towards Targeted Therapies for Triple-Negative Breast Cancer.

Kagihara JA, Shagisultanova E, Afghahi A, Diamond JR. Kagihara JA, et al. Curr Breast Cancer Rep. 2021 Sep;13(3):216-226. doi: 10.1007/s12609-021-00416-0. Epub 2021 May 4. Curr Breast Cancer Rep. 2021. PMID: 34457184 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page